Agency / Source: Royal DSM N.V.

Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Health Tech Company Hologram Sciences Launches Personalized Health & Nutrition Innovation with $100 Million Backing - Royal DSM announced the launch of Hologram Sciences, a consumer-facing company that will create brands targeting various health conditions (NYSE; IPOE) - HologramSciences.com / DSM.com
Health Tech Company Hologram Sciences Launches Personalized Health & Nutrition Innovation with $100 Million Backing

 

PRZOOM - /newswire/ - New York City, NY, United States, 2021/04/05 - Royal DSM announced the launch of Hologram Sciences, a consumer-facing company that will create brands targeting various health conditions (NYSE; IPOE) - HologramSciences.com / DSM.com. Euronext: DSM KON

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Royal DSM, a global science-based company in nutrition, health and sustainable living, announced the launch of Hologram Sciences, a consumer-facing company that will create brands targeting various health conditions.

By combining health diagnostics, digital coaching and personalized nutrition, Hologram Sciences brands will provide consumers with more holistic solutions to manage their health. The mission-driven company combines top Silicon Valley talent, formerly of Uber, Fitbit and Facebook.

Hologram Sciences (hologramsciences.com) is backed with a $100 million investment by Royal DSM (dsm.com), which has made personalized nutrition a key pillar in its nutrition strategy, allowing the company to combine a range of capabilities and resources to cover the entire personalized nutrition value chain all the way to the consumer. Hologram Sciences will provide state-of-the-art consumer-facing personalized nutrition solutions that have been clinically proven to address a variety of consumer health needs. As solutions are validated in-market, they will be available to DSM customers. Hologram will also work to incubate products with DSM customers and partners, based on the latest consumer insights and leveraging their agile approach.

Ian Brady, who co-founded U.S. financial services firm SoFi, will lead Hologram Sciences. Brady transitioned from a successful career in finance to health tech after his wife was diagnosed with gestational diabetes for the third time. In his research to find a personalized nutrition service for his wife and others, he came up empty, prompting this entrepreneur to create one.

“I am excited to be advancing the availability of personalized nutrition so no one else needs to go through the struggles my family experienced,” Brady said. “With a highly dynamic team combining expertise in tech, brand marketing, and the nutrition innovation and science power of DSM, we can reveal that our first solution will be a rapid immunity concept, addressing the current acute concern over the ongoing COVID-19 pandemic."

Along with nutritional supplements and diagnostics, the company’s proprietary digital platform will provide consumers with a personalized experience including access to registered dietitians, allowing them to better understand how their lifestyle, nutrition and other factors impact overall health and what they can do to live healthier lives.

“We’re thrilled to fund a powerful, data-driven platform that’s fused with DSM’s capabilities and product resources,” said Dimitri de Vreeze, Co-CEO at DSM. “With the help of key experts - including nutritionists, dietitians, scientists and advisors - Hologram Sciences will be taking personalized nutrition to a new level for consumers and DSM’s customers.”

The focus on wellness and nutrition is a core value within Hologram Sciences itself, where leaders built a value system based on integrity, accountability and inclusiveness.

“We’re looking to bring mission-driven change to the wellness marketplace by recruiting a passionate team,” said Hologram Sciences chief marketing officer, Jess Graham, who previously served as global head of consumer product marketing for Instagram. “We want to create a world where Hologram Sciences products are the best in helping people live healthier lives.

Hologram Sciences is rapidly expanding its team to bring together people who are passionate about using pioneering science and technology to reimagine the future of nutrition. Graham and Brady will be joined by an experienced, entrepreneurial and global executive team that includes:

• Nate Matusheski, Ph.D., chief science office;
• Thomas McMennemin, chief product officer;
• Laura Artigas, chief commercial officer.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: Royal DSM N.V.

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+]  / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma / BioTech / Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Health Tech Company Hologram Sciences Launches Personalized Health & Nutrition Innovation with $100 Million Backing

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
Royal DSM | Hologram Sciences
Contact: Nelleke Barning - DSM.com 
+41 618 158 502 nelleke.barning[.]dsm.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Royal DSM N.V. securities in any jurisdiction including any other companies listed or named in this release.

Pharma / BioTech / Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Press Releases From Royal DSM N.V. / Company Profile


Read Pharma / BioTech / Nutrition Most Recent Related Press Releases:

DSM to Acquire First Choice Ingredients to Accelerate Growth in Food and Beverage
STEMCELL Technologies Launches Human Pluripotent Stem Cell Characterization and Banking Services in Partnership with WiCell
Biocon Selects TrackWise to Enable Enterprise Quality Management Across Global Biopharmaceutical Operations
STEMCELL Technologies and Hubrecht Organoid Technology to Partner on Non-Oncology Organoid Drug Screening Services
Ipsen and Exicure Enter into Exclusive Collaboration Targeting Rare Neurodegenerative Disorders
Ipsen Strengthens its Pre-clinical Oncology Pipeline with An Exclusive Worldwide-collaboration with BAKX Therapeutics, Inc. for BKX-001
Pharma and Biotech to Highly Invest in RNA Therapeutics to Expedite Research & Development across the Globe Finds Frost & Sullivan
Parexel Commended by Frost & Sullivan for Developing a Flexible and Agile Delivery Model to Improve Clinical Trial Outcome
Ipsen and IRLAB Enter Exclusive Worldwide Licensing Agreement Aimed to Improve the Lives of People Living with Parkinson’s Disease
Exelixis and Ipsen Announce Cabozantinib in Combination with An Immune Checkpoint Inhibitor Significantly Improved Progression

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
.



PREMIUM Members


Visit  BizJobs.com

Visit  JobsWare.com

Visit  La Bella Bakery Artisan Bakery Arizona







 
  ©2021 PRZOOM - Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today